Table 1
Histology and clinical
characteristics of primary ovarian tumors. (serous, endometrioid, clear cell - CA125 levels, menopausal status,patient age)
Background
Epithelial ovarian carcinoma is a significant cause of
cancer mortality in women worldwide and in the United States. Epithelial
ovarian cancer comprises several histological subtypes, each with
distinct clinical and molecular characteristics. The natural history of
this heterogeneous disease, including the cell types of origin, is
poorly understood.
Significance: The significant difference in DNA
methylation profiles between ovarian cancer cell lines and tumors
underscores the need to be cautious in using cell lines as tumor models
for molecular studies of ovarian cancer and other cancers.
Similarly,
the distinct methylation profiles of the different histological types of
ovarian tumors reinforces the need to treat the different histologies
of ovarian cancer as different diseases, both clinically and in
biomarker studies.
Discussion: We quantitatively assessed the DNA methylation status of 1,505 CpG
sites, (associated with 808 genes), in 15 commonly used ovarian cancer
cell lines and 27 primary ovarian tumors, 15 serous (55.5%), 9
endometrioid (33.3%) and 3 clear cell (11.1%). These proportions roughly
reflect the relative frequencies of the different histologies of
ovarian carcinoma diagnosed in the US (serous tumors 50%, endometrioid
25–30%, mucinous 10–15%, clear cell 5%, and others <5%. .... Although the numbers of some subtypes, such as clear cell tumors, were
small, unsupervised and supervised analyses of the DNA methylation
profiles of the primary tumors indicate clear differences between the
histological types....The distinctness of the DNA methylation profiles of the histological
subtypes is suggestive of different tumorigenic mechanisms and/or cells
of origin and underscores the need to view the different histological
types of ovarian cancer as different diseases. While this notion is
common knowledge among clinicians, and is reflected in studies of tumor
gene expression and protein expression,
regrettably, it is often ignored in molecular diagnostic studies, and
all cases of ovarian cancer are still treated similarly in clinic
despite their acknowledged differences in pathology....Additional profiling of primary tumors and corresponding normal tissues
(fallopian tube, ovarian surface epithelium, peritoneum or endometrium)
as well as measurements of methylated DNA in candidate detection media
(blood or proximal fluids) in both health and disease will help define
the natural history of ovarian cancers and critically assess the
potential utility of DNA methylation based biomarkers in combating
ovarian cancer.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.